🇺🇸 Blood component A in United States

Blood component A (Blood component A) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Blood component A in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Blood component A approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Blood component A in United States?

Università degli Studi di Ferrara is the originator. The local marketing authorisation holder may differ — check the official source linked above.